Molecular insights into ubiquitin remodelling factor p97(VCP) in DNA damage response and genome stability

Lead Research Organisation: University of Oxford
Department Name: UNLISTED

Abstract

The realisation of this programme will not only contribute to gaining knowledge about the mechanistic function of p97, its adapter and substrates, in the DDR, but will also have a direct impact on the development of novel small-molecule molecularly-targeted cancer drugs for use in combination therapy. The impact of this knowledge and any new agents will contribute to the scientific literature and influence on-going research both within the Gray Institute, the research community in the wider University, and national and international research.
The clinical impact of identifying p97 adapters and substrates that are involved in DSB repair after ionizing-radiation and/or DNA replication fork progression and stability will be to provide powerful biomarker tools. First the establishment of cancer or genome instability diagnostic biomarkers; a direct example of this is our discovery of C1orf124/DVC1 mutation in genetically uncharacterized WRN-like syndrome. This work also has ramifications of importance for biomarkers for precise cancer prognosis, as well as predictive biomarkers for therapeutic intervention. Thus clinicians will have a range of powerful tools that are able to identify patient groups, understand their cancer progression and predict their treatment outcome.

Technical Summary

The goal of this current proposal is to understand and identify the specific role of p97 and its adapters in DNA replication and repair. In addition, we will elucidate the composition of the p97-complex, namely the p97-adapter interactome and p97-substrate proteome. By identifying this complex, we aim to define new targets using agents directed to the p97 complex, for the future development of combination therapy with either chemotherapy and radiotherapy; improving the efficacy of these modalities in the treatment of cancer.
Our specific hypothesis is that a unique p97-adapter composition regulates the removal of K48-polyubiqutinated substrates from sites of DNA double strand breaks (DSB), and that a similar mechanism regulates progression of DNA replication fork. This hypothesis will be tested through the following objectives:
Objective 1: Identify the p97-adapters composition from the UBX-protein family and determine their function in DSB repair:
i) We will identify the UBX-proteins (all of which are p97 adapters) involved in regulation of K48-ubiquitin signal at sites of DSBs; we will determine whether identified UBX-protein(s) regulate p97 recruitment at sites of DSB; establish whether identified UBX-protein(s) are involved in regulation of p97-K48-polyubiquitinated substrates after genotoxic stress; if p97 and identified UBX-protein(s) form physical complexes on chromatin; and finally, visualize DSB-related UBX-proteins at sites of DSB.
ii) Identified UBX-proteins will then be tested for their specificity in DSB repair.
Objective 2: Determine p97 substrates, on damaged and undamaged chromatin:
We will identify p97 adapters which govern p97 chromatin function, under physiological and genotoxic conditions; categorise the p97 substrates on the chromatin under these conditions; and ascertain which p97 processing factors are responsible for ubiquitination and deubiquitination of different substrates during DNA replication and repair.
Objective 3: Determine the mechanism of p97 function in DNA replication, in particular after DNA replication fork collapse:
We will assess the role of p97 in the regulation of RNF8 in DNA replication and genome stability, with special focus on UBX-family and DVC1 adapters. We will establish the role of RNF8 activity during DNA replication, and how p97 controls this process; the role of 53BP1 in DNA replication stress and how p97-DVC1 complex controls this; determine the p97 adapters involved in these processes and thus the relevance for the maintenance of DNA replication forks and; finally to determine if there are direct physical and functional interactions between RNF8-53BP1-DVC1-p97 in DNA replication and replication-related repair.

People

ORCID iD

Publications

10 25 50
 
Description Breast Cancer Now/Targeting SPRTN protease to overcome PARP inhibitor resistance in breast cancers
Amount £199,662 (GBP)
Funding ID 2019DecPR1406 
Organisation Breast Cancer Now 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2020 
End 03/2023
 
Description Characterisation of SPRTN protease in DNA replication and repair of Top1-cleavage complex
Amount £36,000 (GBP)
Organisation Nuovo Soldati Foundation for Cancer Research 
Sector Charity/Non Profit
Country Switzerland
Start 10/2020 
End 09/2023
 
Description DNA­-protein crosslink repair: characterization and regulation of a novel repair machinery.
Amount £60,000 (GBP)
Funding ID ALTF 1109-2017 
Organisation European Molecular Biology Organisation 
Sector Charity/Non Profit
Country Germany
Start 08/2018 
End 07/2020
 
Description LAB282 Award
Amount £500,000 (GBP)
Organisation LAB 282 
Sector Charity/Non Profit
Start 10/2017 
End 09/2020
 
Description The role of autophagy in reparing chemotherapy-induced DNA lesions in cancer
Amount £36,000 (GBP)
Funding ID 14548187 
Organisation Fonds National de la Recherche (FNR) 
Sector Charity/Non Profit
Country Luxembourg
Start 10/2020 
End 09/2023
 
Title ATX3 variants inducible cell lines 
Description We have created doxycycline inducible HEK293 cell lines to express various ATX3 variants. 
Type Of Material Cell line 
Year Produced 2019 
Provided To Others? Yes  
Impact -one original scientific publication 
URL https://pubmed.ncbi.nlm.nih.gov/31613024/
 
Title Ataxin 3-knock out HeLa, HEK293 and U2OS cell lines 
Description We have created Ataxin 3 knock out in three human cell lines (HeLa, HEK293 and U2OS). 
Type Of Material Cell line 
Year Produced 2019 
Provided To Others? Yes  
Impact We have directly demonstrated that Ataxin 3 is essential for DNA repair in response to IR. One original scientific publication. 
URL https://pubmed.ncbi.nlm.nih.gov/31613024/
 
Title BrdU assay for ssDNA 
Description We have improved a method for better visualisation of single stranded DNA fragments in human cells. 
Type Of Material Technology assay or reagent 
Year Produced 2021 
Provided To Others? Yes  
Impact - one original research publication - this protocol has also been published 
URL https://pubmed.ncbi.nlm.nih.gov/34888531/
 
Title SPRTN haploinsufficient HeLa Cell Line 
Description We have created a SPRTN haploinsufficient cell line and published this tool in Vaz et al. Mol Cell 2016 
Type Of Material Cell line 
Year Produced 2016 
Provided To Others? Yes  
Impact We have directly demonstrated that inactivation of SPRTN causes formation of endogenous DNA-protein cross links. Other researchers requested this cell line for their work and we provided it by the MTA. 
URL https://pubmed.ncbi.nlm.nih.gov/27871366/
 
Title TEX264 knock out HeLa and HEK293 cell lines 
Description We have created TEX264 knock out HeLa and HEK293 for our research. 
Type Of Material Cell line 
Year Produced 2020 
Provided To Others? Yes  
Impact Using this tool we have directly validated our findings in human cells and demonstrated that TEX264 is essential for Top1-cc repair. One original scientific publication. A new project has been awarded based on this discovery. 
URL https://pubmed.ncbi.nlm.nih.gov/32152270/
 
Description Andrew N J Tutt 
Organisation Institute of Cancer Research UK
Country United Kingdom 
Sector Academic/University 
PI Contribution We investigated the mechanistic insight of the PARP1-p97 interaction.
Collaborator Contribution Prof Tutt team provided mouse and patient breast cancer organoids essential for our research.
Impact -original scientific publication
Start Year 2020
 
Description Dr Raimundo Freire; ATX3 in DNA replication and repair 
Organisation University of La Laguna
Country Spain 
Sector Academic/University 
PI Contribution We have discovered the deubiquitinase Ataxin 3 (ATX3) in DNA damage response and DNA replication. We are analysing p97 proteome after ionizing radiation.
Collaborator Contribution My partner developed ATX3 specific antibodies and purified ATX3 protein. My partner is performing bioinformatic analysis of p97 proteome after ionizing radiation.
Impact -Abhay et al., EMBO J, 2019.
Start Year 2017
 
Description Jiri Bartek, PARP1-p97 study 
Organisation Danish Cancer Society
Department Danish Cancer Society Research Center
Country Denmark 
Sector Academic/University 
PI Contribution We have found that the p97 ATPase removes cytotoxic trapped PARP1 from chromatin.
Collaborator Contribution -provided p97 inhibitor CuET
Impact -original scientific publication
Start Year 2019
 
Description Prof Christopher J Lord 
Organisation Institute of Cancer Research UK
Country United Kingdom 
Sector Academic/University 
PI Contribution We performed biochemical analysis of PARP1 interaction with the p97 system.
Collaborator Contribution My collaborator identify the interaction between PARP1 and the p97 system by mass-spectrometry analysis.
Impact -grant award -original scientific publication -connection with other research groups (networking) Yes, this collaboration is multi-disciplinary, between clinical oncologists, clinical scientists and basic scientists.
Start Year 2019
 
Description Prof Dianov; Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients. 
Organisation Russian Academy of Sciences
Department Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Country Russian Federation 
Sector Public 
PI Contribution My team and I have analysed DNA-protein crosslinks in cells where XRCC1 and ALDH2 were inactivated. We are currently working on the regulation of G1/S checkpoint by the NUCKS1-SKP2 axis.
Collaborator Contribution My partner (Prof Dianov) found that low ALDH2 expression levels associated with high XRCC1 expression levels are indicative for a poor overall survival, particularly in lung and liver cancer patients. In addition, they found that Mithramycin A, a XRCC1 expression inhibitor, efficiently kills cancer cells expressing low levels of ALDH2. My partner (Prof Dianov) has identified the NUCKS1-SKP2 axis.
Impact Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients. Chen X, Legrand AJ, Cunniffe S, Hume S, Poletto M, Vaz B, Ramadan K, Yao D, Dianov GL. Cell Oncol (Dordr). 2018 Oct;41(5):527-539. doi: 10.1007/s13402-018-0390-8. Epub 2018 Aug 7. PMID: 30088263 A unified model for the G1/S cell cycle transition. Hume S, Dianov GL, Ramadan K. Nucleic Acids Res. 2020 Dec 16;48(22):12483-12501. doi: 10.1093/nar/gkaa1002.
Start Year 2017
 
Description Prof Dianov; NUCKS1-SKP2-p21/p27 axis controls S phase 
Organisation University of Oxford
Department Department of Oncology
Country United Kingdom 
Sector Academic/University 
PI Contribution We have delineated the molecular mechanism of NUCKS1-SKP2-p21/p27 axis and how it controls S phase entry.
Collaborator Contribution Prof Dianov initiated this project and helped us to recruit one fully-funded DPhil student.
Impact -original scientific publication -review paper -one DPhil student
Start Year 2017
 
Description Prof Geoff S Higgins, TOPK sensitises tumour cells 
Organisation University of Oxford
Department Department of Oncology
Country United Kingdom 
Sector Academic/University 
PI Contribution We analysed how TOPK regulates DNA replication.
Collaborator Contribution Prof Higgins groups found that targeting TOPK sensitises tumour cells to radiation-induced damage.
Impact -two original scientific publications
Start Year 2019
 
Description Prof Kiltie; MRN disassembly 
Organisation University of Oxford
Department Department of Oncology
Country United Kingdom 
Sector Academic/University 
PI Contribution We have discovered how MRN complex, the main DNA double strand break nuclease, is disassembled and regulated at sites of DNA double strand break after ionising radiation.
Collaborator Contribution Prof Kiltie validated this model in a mouse system and patient materials.
Impact -original scientific publication -review publication -one shared DPhil student This is multidisciplinary collaboration between clinical oncologists and basic scientists.
Start Year 2017
 
Description Prof Yosef Shiloh: Investigation of the novel E3 ubiquitin ligases in DNA damage response , Tel Aviv University, Israel 
Organisation Tel Aviv University
Country Israel 
Sector Academic/University 
PI Contribution We have characterised the recruitment of two new E3-ubiquitin ligases to sites of DNA lesions.
Collaborator Contribution The group of Prof Shiloh has identified two new ubiquitin ligases by high-throughput screen.
Impact We have discovered the importance of fine-tuning of the ubiquitin signal at sites of DNA double strand breaks for cell survival. This discovery resulted in one original scientific publication in a prestigious scientific journal, Molecular Cell.
Start Year 2017
 
Description Prof. Vallis; A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator. 
Organisation University of Oxford
Department Department of Oncology
Country United Kingdom 
Sector Academic/University 
PI Contribution My team and I have analysed DNA replication fork progression and elucidated one of the mechanisms how a ruthenium(ii) metallo-intercalator causes DNA replication stress and cell killing.
Collaborator Contribution My partners identified ruthenium(ii) metallo-intercalator as a potential chemical that kills human cells.
Impact DOI: 10.1039/C7SC03712K
Start Year 2017
 
Description Yves Pommier_p97-PARP1 study 
Organisation National Institutes of Health (NIH)
Department National Cancer Institute (NCI)
Country United States 
Sector Public 
PI Contribution Elucidating the physical and functional interactions between PARP1 and p97.
Collaborator Contribution Prof Pommier's team reconstituted one part of our findings in vitro.
Impact -original scientific publication
Start Year 2021
 
Description AMAC-COVID19 talk 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact This was a public talk on COVID-19 origin, pathology and vaccine for the Association of Alumni and Friends of Croatian Universities in the United Kingdom (AMAC/Almae Matris Alumni Croaticae UK).
Year(s) Of Engagement Activity 2021
URL https://amacuk.net/godisnja-predavanja
 
Description Public Engagement at UKRI Coffee Morning Webinar 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact To promote my MRC supported research work on Cancer among general public and Macmillan Cancer Support Charity.
Year(s) Of Engagement Activity 2020
 
Description STEM for Britain 2022 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact "STEM for BRITAIN is a major scientific poster competition and exhibition which has been held in Parliament since 1997, and is organised by the Parliamentary & Scientific Committee. Chaired by Stephen Metcalfe MP, its aim is to give members of both Houses of Parliament an insight into the outstanding research work being undertaken in UK universities by early-career researchers".
Year(s) Of Engagement Activity 2022
URL https://stemforbritain.org.uk/
 
Description TV interviews 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Other audiences
Results and Impact More than 10 TV interviews April 2020 until now on COVID-19 pandemic and vaccine development for Croatian National TV and regional TV (Al Jazeera Balkan).
Year(s) Of Engagement Activity 2020,2021
URL https://www.youtube.com/watch?v=o1nS_JLgJsU